Feasibility and Acceptability of Cognitive Bias Modification for Interpretation as an Adjunctive Treatment for OCD and Related Disorders: A Pilot Randomized Controlled Trial.

cognitive bias modification intensive/residential treatment interpretation bias obsessive-compulsive disorder obsessive-compulsive related disorders

Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
03 2022
Historique:
received: 01 03 2021
revised: 26 08 2021
accepted: 16 09 2021
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 6 5 2022
Statut: ppublish

Résumé

Cognitive models implicate interpretation bias in the development and maintenance of obsessive compulsive and related disorders (OCRDs), and research supports Cognitive Bias Modification for Interpretation (CBM-I) in targeting this mechanism. However, prior studies in OCRDs have been limited to nonclinical populations, adolescents, and adults in a laboratory setting. This study evaluated the feasibility and acceptability of CBM-I as an adjunctive intervention during intensive/residential treatment (IRT) for adults with OCRDs. We modified a lab-based CBM-I training for adults seeking IRT for OCRDs, and conducted a feasibility trial (N = 4) and subsequent pilot RCT; participants (N = 31) were randomized to receive CBM-I or psychoeducation. Benchmarks were met for feasibility, acceptability, and target engagement. From pre- to post-intervention, the CBM-I group showed a large effect for change in interpretation bias (d = .90), whereas this effect was trivial (d = .06) for psychoeducation. This was the first study to evaluate CBM-I in naturalistic treatment for adults seeking IRT for OCRDs. Findings support the feasibility and acceptability of CBM-I in this novel sample and setting. A larger scale RCT is needed to determine whether CBM-I can enhance OCRD treatment response.

Identifiants

pubmed: 35227405
pii: S0005-7894(21)00117-9
doi: 10.1016/j.beth.2021.09.002
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

294-309

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Martha J Falkenstein (MJ)

McLean Hospital/Harvard Medical School. Electronic address: mfalkenstein@mclean.harvard.edu.

Kara N Kelley (KN)

McLean Hospital/Harvard Medical School.

Devin Dattolico (D)

McLean Hospital/Harvard Medical School.

Jennie M Kuckertz (JM)

McLean Hospital/Harvard Medical School.

Andreas Bezahler (A)

McLean Hospital/Harvard Medical School.

Jason Krompinger (J)

McLean Hospital/Harvard Medical School.

Christian A Webb (CA)

McLean Hospital/Harvard Medical School.

Courtney Beard (C)

McLean Hospital/Harvard Medical School.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH